Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/6/24 16:20 | 9/4/24 | EDIT | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | EVP,CHIE | 5 | S.d | -268 | 8.31 | 0 | -32 | 142 | D | |||||||||||||||
9/6/24 16:18 | 9/4/24 | EDIT | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | 3 | S.d | -805 | 8.79 | 0 | -92 | 327 | D | |||||||||||||||
7/26/24 17:02 | 7/25/24 | EDIT | Health | BioPrd | Biological Products, (No Diag | Burkly Linda | MA | O | EVP,CHIE | 1 | S | -64 | 5.42 | 0 | -12 | 73 | D | |||||||||||||||
5/22/24 16:30 | 5/20/24 | EDIT | Health | BioPrd | Biological Products, (No Diag | Lucera Erick | MA | O | EVP,CFO | 1 | S | -125 | 5.61 | 0 | -22 | 117 | D | |||||||||||||||
12/7/23 16:30 | 12/5/23 | EDIT | Health | BioPrd | Biological Products, (No Diag | Eaton Bruce | MA | O | EVP,CBO, | 6 | S | -16 | 8.56 | 0 | -2 | 77 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |